Search
Even though case counts are on the decline in much of the country, the White House continues to see a need for federal assistance.
One dose every 12 hours for five days reduces the rate of hospitalization or death due to COVID-19 by nearly 90%, Pfizer says.
The treatment uses two monoclonal antibodies, bamlanivimab and etesevimab, to treat nonhospitalized high-risk COVID-19 patients.
K-8 schools and underserved settings, such as homeless shelters, will get $650 million to expand testing.
The additional doses ordered are projected to provide for continuous delivery through the end of June 2021.
They want the Inspector General to look into reports that millions went to defense contractors for "jet engine parts, body armor and dress uniforms."
An HHS official said that the federal government hopes to provide free COVID-19 vaccines for every American.
Pfizer will deliver the doses in the U.S. if the product receives Emergency Use Authorization or licensure from the FDA.
The projection is based on the current efforts of HHS' Operation Warp Speed, which is pushing for 300 million doses by next flu season.
Spending on the Affordable Care Act marketplaces has decreased, as Veterans Affairs has ramped up IT modernization efforts, according to a Deltak report.